
Erica S Y Lin
Examiner (ID: 4581, Phone: (571)270-7911 , Office: P/2853 )
| Most Active Art Unit | 2853 |
| Art Unit(s) | 2853, 2861 |
| Total Applications | 1103 |
| Issued Applications | 882 |
| Pending Applications | 99 |
| Abandoned Applications | 155 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18461489
[patent_doc_number] => 11685772
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-27
[patent_title] => Mammalian cell culture
[patent_app_type] => utility
[patent_app_number] => 18/066251
[patent_app_country] => US
[patent_app_date] => 2022-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 11421
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18066251
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/066251 | Mammalian cell culture | Dec 13, 2022 | Issued |
Array
(
[id] => 18309900
[patent_doc_number] => 20230113800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => MODULATION OF MICROBIOTA FUNCTION BY GENE THERAPY OF THE MICROBIOME TO PREVENT, TREAT OR CURE MICROBIOME-ASSOCIATED DISEASES OR DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/052379
[patent_app_country] => US
[patent_app_date] => 2022-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18052379
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/052379 | Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders | Nov 2, 2022 | Issued |
Array
(
[id] => 18518704
[patent_doc_number] => 11708587
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Compositions and methods for increasing the efficiency of cell cultures used for food production
[patent_app_type] => utility
[patent_app_number] => 17/929646
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 24
[patent_no_of_words] => 23190
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929646
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929646 | Compositions and methods for increasing the efficiency of cell cultures used for food production | Sep 1, 2022 | Issued |
Array
(
[id] => 18084360
[patent_doc_number] => 11534467
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders
[patent_app_type] => utility
[patent_app_number] => 17/716313
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 47800
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716313
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/716313 | Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders | Apr 7, 2022 | Issued |
Array
(
[id] => 17750861
[patent_doc_number] => 20220229066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => COMPOSITIONS, IMAGING, AND THERAPEUTIC METHODS TARGETING FOLATE RECEPTOR 1 (FOLR1)
[patent_app_type] => utility
[patent_app_number] => 17/573941
[patent_app_country] => US
[patent_app_date] => 2022-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573941
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/573941 | Compositions, imaging, and therapeutic methods targeting folate receptor 1 (FOLR1) | Jan 11, 2022 | Issued |
Array
(
[id] => 18748600
[patent_doc_number] => 11807899
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Biochemical reaction methods and reagents comprising intrinsically disordered regions
[patent_app_type] => utility
[patent_app_number] => 17/531349
[patent_app_country] => US
[patent_app_date] => 2021-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 54
[patent_no_of_words] => 52498
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17531349
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/531349 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Nov 18, 2021 | Issued |
Array
(
[id] => 17383915
[patent_doc_number] => 20220031767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => MODULATION OF MICROBIOTA FUNCTION BY GENE THERAPY OF THE MICROBIOME TO PREVENT, TREAT OR CURE MICROBIOME-ASSOCIATED DISEASES OR DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/501110
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17501110
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/501110 | Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders | Oct 13, 2021 | Issued |
Array
(
[id] => 17356785
[patent_doc_number] => 20220017581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => ANIMAL-FREE DIETARY COLLAGEN
[patent_app_type] => utility
[patent_app_number] => 17/493627
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493627
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/493627 | Animal-free dietary collagen | Oct 3, 2021 | Issued |
Array
(
[id] => 17697321
[patent_doc_number] => 11371037
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-06-28
[patent_title] => Zinc-charged pancreatic enzymes for treatment of cancer and inflammation
[patent_app_type] => utility
[patent_app_number] => 17/374357
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 29
[patent_no_of_words] => 8797
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17374357
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/374357 | Zinc-charged pancreatic enzymes for treatment of cancer and inflammation | Jul 12, 2021 | Issued |
Array
(
[id] => 17665565
[patent_doc_number] => 11359246
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/353313
[patent_app_country] => US
[patent_app_date] => 2021-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 27
[patent_no_of_words] => 127910
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 254
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17353313
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/353313 | Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhibitors | Jun 20, 2021 | Issued |
Array
(
[id] => 17315914
[patent_doc_number] => 20210404962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => CLEAVABLE LINKERS FOR PROTEIN TRANSLATION REPORTING
[patent_app_type] => utility
[patent_app_number] => 17/350881
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16638
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17350881
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/350881 | Cleavable linkers for protein translation reporting | Jun 16, 2021 | Issued |
Array
(
[id] => 17149492
[patent_doc_number] => 11142555
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-10-12
[patent_title] => Recombinant milk proteins
[patent_app_type] => utility
[patent_app_number] => 17/326785
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 30
[patent_no_of_words] => 21543
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17326785
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/326785 | Recombinant milk proteins | May 20, 2021 | Issued |
Array
(
[id] => 17350003
[patent_doc_number] => 11224621
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-18
[patent_title] => Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders
[patent_app_type] => utility
[patent_app_number] => 17/225869
[patent_app_country] => US
[patent_app_date] => 2021-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 119074
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17225869
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/225869 | Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders | Apr 7, 2021 | Issued |
Array
(
[id] => 17005398
[patent_doc_number] => 20210236559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => GENETICALLY ENGINEERED HEMATOPOIETIC STEM CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/222765
[patent_app_country] => US
[patent_app_date] => 2021-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69504
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17222765
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/222765 | Genetically engineered hematopoietic stem cells and uses thereof | Apr 4, 2021 | Issued |
Array
(
[id] => 17453263
[patent_doc_number] => 11268109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => CHO integration sites and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/175025
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 13513
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17175025
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/175025 | CHO integration sites and uses thereof | Feb 11, 2021 | Issued |
Array
(
[id] => 17020893
[patent_doc_number] => 20210244764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => NOVEL CELLULAR RECEPTORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/171329
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47969
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17171329
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/171329 | Cellular receptors and uses thereof | Feb 8, 2021 | Issued |
Array
(
[id] => 17082069
[patent_doc_number] => 20210277075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => ANIMAL-FREE DIETARY COLLAGEN
[patent_app_type] => utility
[patent_app_number] => 17/171874
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23183
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17171874
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/171874 | Animal-free dietary collagen | Feb 8, 2021 | Issued |
Array
(
[id] => 16786109
[patent_doc_number] => 10988521
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-04-27
[patent_title] => Recombinant milk proteins
[patent_app_type] => utility
[patent_app_number] => 17/127418
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 30
[patent_no_of_words] => 21530
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127418
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/127418 | Recombinant milk proteins | Dec 17, 2020 | Issued |
Array
(
[id] => 16893210
[patent_doc_number] => 11034743
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-06-15
[patent_title] => Recombinant milk proteins
[patent_app_type] => utility
[patent_app_number] => 17/127090
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 30
[patent_no_of_words] => 21527
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127090
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/127090 | Recombinant milk proteins | Dec 17, 2020 | Issued |
Array
(
[id] => 17185448
[patent_doc_number] => 20210332333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => METHODS AND COMPOSITIONS FOR PRODUCING ACTIVE VITAMIN K-DEPENDENT PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/951320
[patent_app_country] => US
[patent_app_date] => 2020-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16951320
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/951320 | METHODS AND COMPOSITIONS FOR PRODUCING ACTIVE VITAMIN K-DEPENDENT PROTEINS | Nov 17, 2020 | Abandoned |